TY  - GEN
AU  - Ozkaynak,M Fevzi
AU  - Sahdev,Indira
AU  - Gross,Thomas G
AU  - Levine,John E
AU  - Cheerva,Alexandra C
AU  - Richards,Michael K
AU  - Rozans,Marta K
AU  - Shaw,Peter J
AU  - Kadota,Richard P
TI  - A pilot study of addition of amifostine to melphalan, carboplatin, etoposide, and cyclophosphamide with autologous hematopoietic stem cell transplantation in pediatric solid tumors-A pediatric blood and marrow transplant consortium study
SN  - 1077-4114
PY  - 2008///0820
KW  - Adolescent
KW  - Adult
KW  - Amifostine
KW  - administration & dosage
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Bone Marrow Transplantation
KW  - Bone Neoplasms
KW  - diagnosis
KW  - Carboplatin
KW  - Central Nervous System Neoplasms
KW  - Child
KW  - Child, Preschool
KW  - Combined Modality Therapy
KW  - Cyclophosphamide
KW  - Dose-Response Relationship, Drug
KW  - Drug Administration Schedule
KW  - Drug-Related Side Effects and Adverse Reactions
KW  - Etoposide
KW  - Feasibility Studies
KW  - Hematopoietic Stem Cell Transplantation
KW  - Hodgkin Disease
KW  - Humans
KW  - Hypocalcemia
KW  - chemically induced
KW  - Kidney Neoplasms
KW  - Melphalan
KW  - Neoplasms
KW  - Neuroblastoma
KW  - Pilot Projects
KW  - Recurrence
KW  - Risk Factors
KW  - Sarcoma
KW  - Transplantation, Autologous
KW  - Transplantation, Homologous
KW  - Treatment Outcome
KW  - Wilms Tumor
N1  - Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1097/MPH.0b013e318162bd0c
ER  -